Immunic
Stock Forecast, Prediction & Price Target
Immunic Financial Estimates
Immunic Revenue Estimates
Immunic EBITDA Estimates
Immunic Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $397.02M Low: $397.02M High: $397.02M avg. 0% | Avg: $174.98M Low: $174.98M High: $174.98M avg. -55.92% | Avg: $1.05B Low: $1.05B High: $1.05B avg. 502.44% | Avg: $733.14M Low: $733.14M High: $733.14M avg. -30.45% |
Net Income
% change YoY
| $-92.79M N/A | $-154.29M -66.27% | $-93.61M 39.32% | Avg: $-100.09M Low: $-42.99M High: $-31.91M avg. -6.92% | Avg: $44.97M Low: $-45.64M High: $226.47M avg. 144.93% | Avg: $116.11M Low: $116.11M High: $116.11M avg. 158.16% | Avg: $190.57M Low: $190.57M High: $190.57M avg. 64.12% |
EBITDA
% change YoY
| $-91.66M N/A | $-53.54M 41.58% | $-99.11M -85.09% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$3.92 N/A | -$4.85 -23.72% | -$2.11 56.49% | Avg: -$0.88 Low: -$0.97 High: -$0.72 avg. 58.41% | Avg: $1.03 Low: -$1.03 High: $5.11 avg. 217.37% | Avg: $2.62 Low: $2.62 High: $2.62 avg. 154.36% | Avg: $4.3 Low: $4.3 High: $4.3 avg. 64.12% |
Operating Expenses
% change YoY
| $91.66M N/A | $86.51M -5.61% | $99.22M 14.68% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Immunic stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 90.07% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -42.99M, average is -100.09M and high is -31.91M.
What is Immunic stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 104.01% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $397.02M, average is $397.02M and high is $397.02M.
What is Immunic stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 123.57% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.97, average is -$0.88 and high is $-0.72.
What is the best performing analyst?
In the last twelve months analysts have been covering Immunic stock. The most successful analyst is Market Perform.